cancer cells through various mechanisms in the process of tumorigenesis. Insights into the molecular function of tumor suppressors could aid in understanding pathways and barriers that prevent the process of tumor progression. 3 Phosphatase and tensin homolog (PTEN), a tumor suppressor gene, is frequently mutated in a variety of human cancers including prostate cancer. 4, 5 PTEN negatively regulates the PI3-kinase pathway, a critical oncogenic signaling pathway, which regulates diverse cellular processes such as survival, proliferation, growth, and cell migration. Several ligands acting through different receptors activate PI3-kinase which then converts PIP 2 to PIP 3 . 6 AKT (also known as protein kinase B), an important downstream effector of PIP 3 is then recruited to the membrane via PIP 3 and is phosphorylated by phosphoinositide dependent protein kinase-1 (PDK1) at threonine 308. Mammalian target of rapamycin complex 2 (mTORC2) has been shown to be involved in phosphorylating AKT at serine 473 which, along with phosphorylation at threonine 308 by PDK1, is required for full activation of AKT which in turn activates mTORC1 complex. 6, 7 PTEN negatively regulates the PI3-kinase/AKT/mTOR pathway by dephosphorylating PIP 3 to PIP 2 and directly opposes the action of PI3-kinase. PTEN has a crucial role in controlling cell death, cell proliferation, cell migration, and considerable evidences indicate that PTEN loss of function results in up-regulation of the PI3-kinase/AKT/mTOR signaling pathway in prostate cancer, primarily through the activation of AKT. [8] [9] [10] [11] Activating mutations of the PI3-kinase pathway and loss of PTEN are extremely common in advanced cancer tumor progression, 12 and has been previously shown that PTEN mutations in prostate cancers have led to higher basal levels of phosphorylated AKT (pAKT Ser473 ) and increased survival of cells. [12] [13] [14] Transforming growth factor-β (TGF-β) is a secreted cytokine and a major regulator of many cellular processes implicated as factors in cancer formation and progression such as proliferation, survival, migration/invasion, and metastasis. 15 TGF-β acts as a tumor suppressor inhibiting proliferation in normal epithelial cells and early stages of many cancers, while in later stages, it exerts pro-oncogenic roles by promoting epithelial to mesenchymal transformation (EMT) which converts metastatic epithelial cells into highly invasive mesenchymal cells, a necessary pre-requisite for tumor cell metastasis. [16] [17] [18] The three TGF-β isoforms, TGF-β1, TGF-β2, and TGF-β3 have been identified in mammalian cells and share a 70-80% sequence homology in most organisms and play redundant roles in cancer cells. [19] [20] [21] All three TGF-β isoforms signal by binding to TGF-β Receptor II (TGF-βRII) which activates TGF-β Receptor I (TGF-βRI) which in turn, recruit and phosphorylates receptor associated-Smads (R-Smads), Smad2, and Smad3, which then form heterodimeric complexes with Smad4 that are then translocated into the nucleus where it functions to regulate transcriptional target genes. 20, 22 It has been suggested that TGF-β1
and TGF-β3 share a similar receptor binding affinity to TGF-βRII and can exert similar biological effects on target cells. TGF-β2, on the other hand binds to TGF-βRII with an affinity that is 100-1000-fold lower, and requires TGF-β Receptor III (TGF-βRIII) (β-glycan) to promote receptor assembly. 19, 23, 24 Previous studies also demonstrated that TGF-β3 increased the invasiveness of endometrial carcinoma cells via a Phosphatidylinositol-3
Kinase (PI3-kinase)-dependent pathway, which were distinct from TGF-β1. 25, 26 Our laboratory has shown TGF-β effects on migration and invasion of prostate cancer cells, and these effects are dependent on both TGF-βRI and Smad3, and are mediated via the PI3-kinase pathway. 19 In our studies, TGF-β3 was found to be more potent than Previous evidence has clearly suggested the involvement of the PI3-kinase signaling pathway mediating TGF-β effects on cancer cell invasion and metastasis. 19, 31, 32 A recent report confirmed an isoformspecific role of TGF-β in the migration and invasion of the metastatic PC3 prostate cancer cells, which are dependent on the activation of the PI3-kinase pathway. 19 However, in DU145 prostate cancer cells, the effects of TGF-β isoforms on the activation of PI3-kinase and the phosphorylation of AKT were not observed. 19 This suggests that one possible contributor of differential effects of TGF-β on the activation of PI3-kinase may be PTEN. PTEN is expressed in the DU145 prostate cancer cell line, but is deleted in PC3 cells. [33] [34] [35] [36] Another study indicated that the loss of PTEN expression in human cancers may contribute to a role for TGF-β as a tumor enhancer with specific effects on cellular motility and invasion. 37 Although previous studies confirmed a role of TGF-β in migratory and invasive behavior in metastatic prostate cancer cells, which are dependent on the activation of the PI3-kinase pathway, the role of PTEN in TGF-β effects on the activation of PI3-kinase in prostate cancer cells remains to be elucidated. In this study, we investigated the effects of TGF-β on PTEN expression in prostate cancer cells, and whether PTEN plays a role in TGF-β-induced effects on proliferation, migration, and the activation of PI3-kinase/AKT pathway.
Life Technologies (Grand Island, NY). Anti-mouse IgG HRP was obtained from GE Healthcare (Piscataway, NJ). Earle's salts with 0.1 mM of the following amino acid supplements:
| Cell lines and cell culture
L-serine, and L-glycine. The medium contained 4 mM L-glutamine, 2.5 g/L NaHCO 3 , 1.5 mM HEPES, 100 U/mL penicillin, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B, and 50 μg/mL gentamycin.
MEM and RPMI media (Mediatech, Herndon, VA) were supplemented with 5% fetal bovine serum (HyClone, South Logan, UT).
| RNA isolation, cDNA synthesis, and RT-PCR
Total RNA was isolated from normal prostate and prostate cancer cells using TRIzol (Invitrogen, Carlsbad, CA). The RNA samples were quantified by optical density reading at 260 nm as described previously 40 ; OD260/OD280 ratio for RNA samples were between 
| Cell treatments
To determine the effects of TGF-β isoforms on PTEN, pAKT 
| Transwell cell migration assay
In vitro cell migration assay was performed using a 24-well plate transwell inserts (8 μm) as previously described. 42 were expressed as invasion index defined as the sum of 10 random fields for test substance/the sum of 10 random fields for the medium control.
| Cell proliferation assay
The cell growth assay was performed by counting the number of cells.
Cells were seeded at a density of 1 × 10 5 cells overnight in six-well plates and treated the next day with TGF-β1 or TGF-β3 (5 ng/mL) or combination of both (TGF-β1 and TGF-β3), in culture media containing 1% FBS for specific time points. Cells were then trypsinized and counted using the Cellometer Vision System (Nexcelom Bioscience LLC, Lawrence, MA).
| Transfection with specific plasmids and small interfering (si) RNAs
Cells were seeded at a density of 1 × 
| Statistical analysis
All experiments were performed at least three times using different cell 3 | RESULTS
| Expression of PTEN in prostate cell lines
Gene expression of PTEN in prostate cells was determined using semiquantitative RT-PCR across four established prostate cell lines (RWPE1, LNCaP, DU145, and PC3). PTEN mRNA was detectable in three of the four cell lines with no detectable expression in PC3 cells ( Figure 1A) . To examine the presence of PTEN protein and pAKT Ser473 in these cell lines, the total cell lysate proteins were analyzed using Western blotting ( Figure 1B Figure 1C ).
| TGF-β isoforms increase intracellular PTEN protein levels in DU145 and RWPE1 cells
Next, we investigated the effects of TGF-β isoforms on the expression of PTEN in DU145 and RWPE1 cells. DU145 and RWPE1 cells were treated with different concentrations of TGF-β1 and/or TGF-β3 for specific times. As shown in Figure 2A , TGF-β3 had no effect on the mRNA levels of PTEN in DU145 cells, as determined by RT-PCR analysis. We also confirmed the lack of TGF-β effects on PTEN mRNA levels by real time PCR (data not shown). However, as shown in and also in RWPE1 cells at 4 h (2.0 ± 0.14-fold; P < 0.05) and 8 h (1.7 ± 0.31-fold; P < 0.05) ( Figure 2B ). As shown in Figure 2C , TGF-β3 treatments significantly increased PTEN protein levels in a dose-dependent manner in DU145 cells after 4 h at 1 ng/mL (1.7 ± 0.26-fold; P < 0.05), 5 ng/mL (2.2 ± 0.12-fold; P < 0.05), and 10 ng/mL (2.15 ± 0.103-fold; P < 0.05). As shown in Figures 2B and 2C , TGF-β1 (5 ng/mL) treatment also caused an increase in PTEN protein levels in both DU145 and RWPE1 cells. In DU145 cells, TGF-β1 treatment significantly increased PTEN protein levels at 4 h ( Figure 2B) (1.9 ± 0.10-fold; P < 0.05), and in a dose-dependent manner after 4 h at 5 ng/mL (1.38 ± 0.149-fold; P < 0.05) ( Figure 2C ), however, the increase in PTEN protein levels in TGF-β1 treated RWPE1 cells was not statistically significant ( Figure 2C ). These results suggest that both TGF-β1 and TGF-β3 increase PTEN protein levels; however, TGF-β3 effects on both cell lines are more pronounced. TGF-β signaling is initiated by binding of the ligand to TGF-βRII that form heterodimers with TGF-βRI leading to Smad2 and Smad3 phosphorylation.
Therefore, we examined whether TGF-β effects on PTEN are mediated by this canonical signaling pathway. We determined the effects of TGF-β on the phosphorylation of Smad2 and Smad3 in both DU145
and RWPE1 cells. Western blot analysis showed that TGF-β isoforms induced both Smad2 and Smad3 phosphorylation in a time-dependent manner ( Figures 3A and 3B) . 
| TGF-β isoforms exert differential effects on cell proliferation and migration in prostate cancer cells
In previous studies, TGF-β has been shown to exert differential biological effects in different prostate cancer-derived cell lines. 27, 30 To confirm these studies, we first determined the effects of TGF-β1 and TGF-β3 (5 ng/mL) and the combination of both (TGF-β1 and TGF-β3) on cell proliferation in DU145 prostate cancer cells ( Figure 4A ). Both TGF-β isoforms caused a significant inhibition of cell proliferation in DU145 cells with no differences in the potencies of the two isoforms.
Treatment with TGF-β1 resulted in 33% (P < 0.05) inhibition, TGF-β3 resulted in 42% (P < 0.05) inhibition, and both TGF-β1 and TGF-β3 combined resulted in 44% (P < 0.05) inhibition of proliferation in DU145 cells. There was no synergistic or additive effect of two isoforms on cell proliferation.
We also determined the effects of TGF-β1 and TGF-β3 (5 ng/mL) on cell migration in PC3 prostate cancer cells ( Figure 4B ). Both TGF-β isoforms induced migration in PC3 cells (TGF-β1; 1.4 ± 0.75 migration index; P < 0.05) and TGF-β3; 1.52 ± 0.13 migration index; P < 0.05),
TGF-β1 and TGF-β3; 1.54 ± 0.11 migration index; P < 0.05). The two isoforms did not exhibit synergistic or additive effects. Epidermal growth factor (EGF) used as a positive control, induced cell migration in PC3 (1.7 ± 0.05 migration index; P < 0.05) cells ( Figure 4B ).
| Reduction in levels of PTEN protein leads to attenuation of inhibitory effects of TGF-β on proliferation in prostate cancer cells
We have previously shown that TGF-β exerts differential effects on cell proliferation of different prostate cancer cell lines. 28, 30, 44 TGF-β isoforms caused a significant inhibition of cell proliferation in DU145 cells ( Figure 5A ). Total Smad (Smad2/3) and β-actin were used as loading controls. Each bar represents mean ± SEM (n = 3). Different letters denote significant differences among various groups (P < 0.05) FIGURE 4 TGF-β isoforms have no synergistic or additive effect on cell proliferation and cell migration in different cell types. A, DU145 cells were treated with TGF-β1 or TGF-β3 (5 ng/mL) or combined (TGF-β1 and TGF-β3) to determine cell proliferation. Each bar represents mean ± SEM (n = 3). *Significantly different (P < 0.05) when compared with appropriate controls. B, Cell migration of PC3 cells across transwell membranes were assayed in response to TGF-β1 (5 ng/mL), TGF-β3 (5 ng/mL), TGF-β1 and TGF-β3 combined, or EGF (10 ng/mL) treatments. EGF was used as a positive control. Each bar represents mean ± SEM (n = 3). Different letters denote significant differences among various groups (P < 0.05)
The possible role of PTEN in proliferation of prostate cancer cells and its role in the effects of TGF-β on cell proliferation were determined using siRNAs to transiently knockdown PTEN proteins in DU145 cells ( Figure 5B Figure 5C ). However, proliferation was significantly reduced in PC3 cells overexpressing PTEN protein and TGF-β isoforms had no effects on proliferation in these cells. cells. 19, 31 To confirm these studies, we determined the effects of TGF-β isoforms on cell invasion in DU145 cells using the BD BioCoat Matrigel Invasion inserts. As shown in Figure 7 , both TGF-β1 and TGF-β3 had no effect on invasiveness in DU145 cells, however, EGF induced invasion (2.9 ± 0.66 invasion index; P < 0.05) in DU145 cells.
| TGF-β isoforms exert differential effects on migratory and invasive properties in prostate cancer
These results suggest that TGF-β isoforms may have differential effects on migration and invasion in prostate cancer cells.
| Re-expression of PTEN inhibits TGF-β induced cell migration in prostate cancer cells
To determine whether PTEN plays a role in TGF-β-mediated effects on migration in prostate cancer cells, we performed transient knockdown of PTEN in DU145 cells using siRNA specific for PTEN ( Figure 8A ).
PTEN protein levels were determined by Western blotting analysis, which confirmed a 54% reduction (P < 0.05) in DU145 cells transfected with PTEN siRNA compared to control siRNA transfected cells ( Figure 8A ). We analyzed migration of DU145 cells after knockdown of PTEN ( Figure 8A ). DU145 cells were treated with TGF-β1 and TGF-β3 (5 ng/mL) for 48 h after transfection with PTEN siRNA. We observed that both TGF-β isoforms induced migration with a significant increase with TGF-β3 (1.6 ± 0.23-fold; P < 0.008) and EGF (1.8 ± 0.07-fold; P < 0.008) ( Figure 8A ). 
| PTEN overexpression inhibit TGF-β effects on the phosphorylation of AKT in prostate cancer cells
To determine whether or not overexpression of PTEN will affect TGF-β effects on the activation of PI3-kinase in PC3 cells treated with TGF-β3 (5 ng/mL) ( Figure 9 ). Western blot analysis revealed that in response to TGF-β3, PTEN overexpressing PC3 cells had significantly 
| DISCUSSION
In this study, we investigated the role of PTEN in TGF-β effects on proliferation and migration of prostate epithelial cancer cells. We report that TGF-β has differential effects on PTEN protein and RNA levels in prostate cancer cells. We also show that PTEN may mediate anti-proliferative effects of TGF-β in prostate epithelial cells. Our results also revealed that lack of PTEN may enhance TGF-β effects on cell migration in prostate cancer cells.
Prostate cancer transpires and progresses as a result of accumulated genomic mutations that lead to unchecked cellular growth and survival of the mutated and dividing cells. 45 The principle problem arising from prostate cancer and its high rate of mortality is due to metastasis of the primary tumor to secondary sites. 46 Cellular migration and invasion play fundamental roles in cancer metastasis.
Among multiple growth factors, TGF-β has been implicated in the regulation of prostate cancer cell proliferation, progression, and/or metastasis. [28] [29] [30] 44, [47] [48] [49] [50] TGF-β is a multiple functional protein that FIGURE 8 Endogenous PTEN inhibits effects of TGF-β on cell migration in prostate cancer cells. A, DU145 cells transfected with control siRNA or PTEN siRNA were treated with TGF-β1 or TGF-β3 (5 ng/mL), or EGF (10 ng/mL) to determine migratory properties in a transwell cell migration assay. Levels of PTEN proteins after transfection with control siRNA or PTEN siRNA in DU145 cells were determined by Western blotting analysis (inset). Each bar represents mean ± SEM (n = 3). *Significantly different (P < 0.05) compared with untreated controls. B, PC3 cells after transfected with pcDNA3 GFP empty vector or pcDNA3 GFP PTEN vector were treated with TGF-β1 or TGF-β3 (5 ng/mL), or EGF (10 ng/mL) to determine migration using a transwell migration assay. Each bar represents mean ± SEM (n = 4). *Significantly different (P < 0.05) when compared with untreated controls. Levels of PTEN proteins and β-actin (used as a loading control) after transfection with empty vector or PTEN vector, in the presence or absence of TGF-β3 or EGF in PC3 cells were determined by Western blotting analysis (inset). DU145 was used as a positive control Earlier studies have addressed the interaction of the PI3-kinase/ PTEN pathway and TGF-β signaling pathways in various cell types.
Previous reports have shown that TGF-β1 regulates PTEN expression in keratinocytes 4 and causes a reduction of PTEN mRNA levels in pancreatic cancer cells. 64 Moreover, inactivation of TGF-β signaling and loss of PTEN cooperate to induce colorectal cancer formation and progression by suppressing cell cycle inhibitors. 65 Although it is known that loss of PTEN expression seems to be more frequent in many human tumors, the expression of PTEN has been associated with inhibitory effects on proliferation, migration, and induction of apoptosis in vitro and in vivo. 64, 66, 67 In the current study, we studied the effects of TGF-β1 and TGF-β3 on PTEN expression in DU145 and RWPE1 cells. Our results show that while TGF-β isoforms had no effect on PTEN mRNA levels; they induced an increase in PTEN protein in both DU145 and RWPE1 cells. TGF-β induced increase in PTEN protein levels may suggest that the level of PTEN may be regulated by TGF-β via other mechanisms such as protein stability and protein degradation. It has been reported previously that PTEN activity may be highly regulated on many levels by posttranscriptional and posttranslational mechanisms. 68 It has also been demonstrated that TGF-β can regulate protein stability via posttranslational modifications. [69] [70] [71] [72] One study revealed that TGF-β increases nuclear p27 levels by preventing proteasomal degradation, specifically by downregulating ubiquitin E3 both isoforms had no effects on migratory behavior in DU145 cells. 19 In another study, TGF-β1 induced cell migration and invasion in PC3 cells but not in in DU145 cells using the transwell insert cell migration assay 27, 31 ; TGF-β3 was not investigated in these studies. Interestingly, our results show that while TGF-β1 had no effects on migration in DU145 cells, TGF-β3 significantly induced migration in both DU145
and PC3 cells. These results support previous findings that TGF-β3 and TGF-β1 exert differential effects on invasive behavior in prostate and other cancer cells. 19, 27, 31 This could either be because of differential potencies of individual isoforms or due to inherent specific signaling pathways utilized by TGF-β1 and TGF-β3. 82 However, the exact mechanisms involved in these differential effects remain unknown.
Interestingly, TGF-β3 had no effects on invasive behavior in DU145 cells although it induced cell migration in these cells. These data indicate that TGF-β3 may exert differential effects on intracellular mechanisms which are involved in induction of cell migration and/or invasion which may play significant role in the progression of invasive and metastatic disease. 19, 20, 32 These observed effects in both DU145
and PC3 cells are specific to TGF-β, since LNCaP cells (used as negative controls due to lack of TGF-βRII) were unresponsive to both isoforms of TGF-β. 19, 83 Similar differential role of TGF-β isoforms is also supported in breast carcinomas, where high expression of TGF-β3
correlates with decreased overall survival rate. 84, 85 It has been confirmed that the isoform specific roles of TGF-β on cell migration and invasion are mediated by TGF-βRI and Smad3 dependent activation of PI3-kinase pathway in metastatic prostate cancer cells. 19 Previous studies have implicated a role for PTEN in repressing the pro-tumorigenic effects of TGF-β; reconstitution of PTEN expression in PTEN-null cells blocked TGF-β-induced invasion, but did not modulate TGF-β-mediated growth regulation. 37 Similarly, in keeping with these studies, our results show that TGF-β induced migration in PTEN knockdown DU145 cells, whereas TGF-β reduced migratory behavior in PTEN overexpression PC3 cells. These results indicate PTEN may play a role in TGF-β mediated effects in regulating tumor cell metastasis. In PC3 cells, overexpression of PTEN has been shown to be associated with a decrease in the levels of pAKT Ser473 . 73 Previously, it has been shown that TGF-β can activate PI3-kinase pathway in prostate cancer cells as shown by increased phosphorylation of AKT, [55] [56] [57] [58] [59] and activation of this pathway is required for its effects on increased migration and invasion of these cells. 32 Here, we 
| CONCLUSION
In conclusion, our results demonstrate that TGF-β increases protein levels of PTEN in prostate cancer cells; however, TGF-β has no effect on mRNA levels of PTEN in these cells. We also show that lack of PTEN led to increased TGF-β effects on migration in prostate cancer cells, whereas overexpression of PTEN, in PTEN null prostate cancer cells, 
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